These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 34531121)

  • 1. Pharmacist provider status: Geoprocessing analysis of pharmacy locations, medically underserved areas, populations, and health professional shortage areas.
    Murphy EM; West L; Jindal N
    J Am Pharm Assoc (2003); 2021; 61(6):651-660.e1. PubMed ID: 34531121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Illustrating access to community pharmacies in Wisconsin.
    Look KA; Dekeyser C; Conjurske S; Platta M; Bohnen C; Black P; Portillo E
    J Am Pharm Assoc (2003); 2021; 61(4):492-499. PubMed ID: 33707122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing community pharmacy services in health professional shortage areas across Wisconsin.
    Look KA; Black P; Arzt J; Crahan J; Helgeson CB; Lucey MS; Lee M; Rox KR; Portillo E
    J Am Pharm Assoc (2003); 2024; 64(2):506-511.e3. PubMed ID: 37940092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacy provision of influenza vaccinations in medically underserved communities.
    Murphy PA; Frazee SG; Cantlin JP; Cohen E; Rosan JR; Harshburger DE
    J Am Pharm Assoc (2003); 2012; 52(1):67-70. PubMed ID: 22257618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and Impact of Pharmacy Students as Patient Care Extenders in Medically Underserved Community Pharmacies.
    White N; Galt K; Ridgway JE; Skrabal MZ; Jones R; Willman CC
    J Pharm Pract; 2021 Jun; 34(3):465-471. PubMed ID: 31615296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacist Provider-Status Legislation Returns.
    Baldwin P
    Sr Care Pharm; 2021 Jul; 36(7):357. PubMed ID: 34144726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Community Pharmacist Provision of Non-Dispensing Services in Health Professional Shortage Areas.
    Kessinger H; Landis E; DiPietro Mager N; Kier K
    Innov Pharm; 2022; 13(4):. PubMed ID: 37305593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Designation of medically underserved populations and health professional shortage areas--HRSA. Proposed rules.
    Fed Regist; 1998 Sep; 63(169):46538-55. PubMed ID: 10182703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacist provider status legislation: Projections and prospects.
    Harper PC
    J Am Pharm Assoc (2003); 2015; 55(2):203-7. PubMed ID: 25749265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eliminating primary care health professional shortage areas: the impact of Title VII generalist physician education.
    Politzer RM; Hardwick KS; Cultice JM; Bazell C
    J Rural Health; 1999; 15(1):11-20. PubMed ID: 10437327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medicare star ratings: stakeholder proceedings on community pharmacy and managed care partnerships in quality.
    Academy of Managed Care Pharmacy ; American Pharmacists Association
    J Am Pharm Assoc (2003); 2014; 54(3):228-40. PubMed ID: 24770440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rethinking access to care: A spatial-economic analysis of the potential impact of pharmacy closures in the United States.
    Adepoju OE; Kiaghadi A; Shokouhi Niaki D; Karunwi A; Chen H; Woodard L
    PLoS One; 2023; 18(7):e0289284. PubMed ID: 37498949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Supporting the provision of pharmacy medication reviews to marginalised (medically underserved) groups: a before/after questionnaire study investigating the impact of a patient-professional co-produced digital educational intervention.
    Latif A; Waring J; Chen LC; Pollock K; Solomon J; Gulzar N; Gulzar S; Anderson E; Choudhary S; Abbasi N; Wharrad HJ; Anderson C
    BMJ Open; 2019 Sep; 9(9):e031548. PubMed ID: 31530620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sexual and reproductive health services provided by community pharmacists: a scoping review.
    Navarrete J; Yuksel N; Schindel TJ; Hughes CA
    BMJ Open; 2021 Jul; 11(7):e047034. PubMed ID: 34312200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transformational strategies for optimizing use of medications and related therapies through us pharmacists and pharmacies: Findings from a national study.
    Thornewill J; Antimisiaris D; Ezekekwu E; Esterhay R
    J Am Pharm Assoc (2003); 2022; 62(2):450-460. PubMed ID: 34758925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Community pharmacy practice in China: past, present and future.
    Fang Y; Yang S; Zhou S; Jiang M; Liu J
    Int J Clin Pharm; 2013 Aug; 35(4):520-8. PubMed ID: 23661172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Community pharmacist-led intervention to identify persons with diabetes not on statin therapy.
    Drake ES; Harris DK; Marciniak MW
    J Am Pharm Assoc (2003); 2018; 58(4S):S125-S130. PubMed ID: 30006183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Medicare Part D on independent and chain community pharmacies in rural Illinois--A qualitative study.
    Bono JD; Crawford SY
    Res Social Adm Pharm; 2010 Jun; 6(2):110-20. PubMed ID: 20511110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pharmacist as a primary care provider for the medically underserved.
    Goyette D; Disco ME; Leal S; Schwed DH
    J Am Pharm Assoc (2003); 2003; 43(5 Suppl 1):S52-3. PubMed ID: 14626534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacist-provided immunization compensation and recognition: white paper summarizing APhA/AMCP stakeholder meeting.
    Skelton JB; ;
    J Am Pharm Assoc (2003); 2011; 51(6):704-12. PubMed ID: 22068191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.